- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
UPDATED Apr 12, 2024
High return on equity, past performance and sound balance sheet.
18 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
500660 | ₹1,884.05 | -2.9% | 49.7% | ₹319.2b | ₹2,141.25 | PE60.3x | E21.1% | 1.7% | ||
500420 | ₹2,576.40 | -0.07% | 63.5% | ₹872.0b | ₹2,723.93 | PE58.4x | E21.3% | 1.2% | ||
500488 | ₹26,465.80 | -0.6% | 17.7% | ₹562.4b | ₹27,670.43 | PE49.1x | E13.2% | 1.2% | ||
BLUEJET | ₹391.80 | -5.3% | n/a | ₹68.0b | ₹430.00 | PE38.9x | E25.9% | n/a | ||
CONCORDBIO | ₹1,560.00 | 1.5% | n/a | ₹163.2b | ₹1,596.80 | PE53.6x | E23.8% | 0% | ||
GLS | ₹808.90 | -1.0% | 93.7% | ₹99.1b | ₹859.00 | PE19.1x | E11.2% | 2.8% | ||
AJANTPHARM | ₹2,115.30 | -3.0% | 68.6% | ₹266.3b | ₹2,271.20 | PE36.2x | E18.0% | 1.7% | ||
524558 | ₹6,660.85 | 4.5% | 220.6% | ₹85.5b | ₹8,300.00 | PE27x | E9.2% | 0.2% | ||
MANKIND | ₹2,320.35 | -1.0% | n/a | ₹929.5b | ₹2,184.17 | PE53.8x | E18.7% | n/a | ||
NATCOPHARM | ₹974.25 | -2.3% | 69.7% | ₹174.5b | ₹930.82 | PE13.7x | E14.3% | 1.0% | ||
524742 | ₹1,293.30 | 0.9% | 105.7% | ₹98.2b | ₹1,579.33 | PE22.4x | E8.1% | 0.4% | ||
524632 | ₹326.00 | 8.2% | 450.8% | ₹3.6b | n/a | PE19.3x | n/a | 0.2% | ||
506260 | ₹233.35 | -6.7% | 158.4% | ₹11.7b | n/a | PE21.5x | n/a | 0.9% | ||
ACCENTMIC | ₹262.55 | -0.4% | n/a | ₹5.5b | n/a | PE42.5x | n/a | 0% | ||
540737 | ₹629.45 | -8.1% | 124.2% | ₹8.1b | n/a | PE36.8x | n/a | 0.08% | ||
RPGLIFE | ₹1,508.85 | -4.3% | 101.7% | ₹25.0b | n/a | PE29.4x | n/a | 0.8% | ||
506820 | ₹5,308.05 | 3.3% | 64.9% | ₹132.7b | n/a | PE95.3x | n/a | 0.3% | ||
530477 | ₹151.65 | 0.8% | 92.6% | ₹4.8b | n/a | PE19.5x | n/a | 0.3% |
Page 1 of 1